evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
Published 8 months ago • 81 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:53
achieving functional cure in transplant-eligible and transplant-ineligible multiple myeloma
-
3:04
individualizing treatment in transplant-eligible & transplant-ineligible ndmm
-
1:05
optimizing the treatment of transplant-eligible ndmm: using quadruplets in induction & consolidation
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
1:29
replacing dexamethasone in transplant-ineligible multiple myeloma: the rest study
-
1:49
the evolving treatment landscape in multiple myeloma & ongoing research
-
5:18
upfront treatment in transplant candidates
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
1:30
the evolving treatment landscape for multiple myeloma
-
0:42
haploidentical transplant in argentina
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
2:10
phase ii study of epd maintenance after second autologous transplant for multiple myeloma
-
2:35
methods of optimizing transplantation in mds
-
2:25
new insight into the biology of multiple myeloma: from clonal evolution to new treatment options
-
0:40
the impact of an evolving first-line setting on subsequent treatment lines in multiple myeloma
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
2:41
an overview of the latest advances in hematology